Blood test to predict best time for embryo transfer in IVF
Part of Women’s health & pregnancy clinical trials.
This study tests if a blood test measuring tiny molecules (miRNAs) can predict when the uterus is most ready for an embryo. It aims to improve IVF success in women with unexplained repeated implantation failure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman under 40 who has had IVF failure after 3 embryo transfers or after transferring at least 3 high-quality embryos.
- Your BMI is between 18.5 and 25.
- Your uterine lining is at least 7 mm thick before embryo transfer.
- You are planning to have a frozen embryo transfer of a blastocyst (a 5-6 day embryo) in an IVF cycle.
- You do not have known causes of implantation failure such as infections, uterine shape problems, endometriosis, or autoimmune diseases.
- You and your partner do not have chromosomal abnormalities (except harmless variations) or family genetic disorders, and you have not had multiple miscarriages.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether checking the timing of the uterine lining (endometrium) before transferring an embryo can help women who have had multiple failed embryo transfers. It aims to improve the chance of a successful pregnancy for women under 35 with no known cause for their infertility.
This trial compares a new method to time a frozen embryo transfer (using a test called ERA) with the standard method. The goal is to find the best time to transfer a high-quality embryo in women who have had multiple failed IVF attempts (recurrent implantation failure).
This study looks at whether immune system or microbiome changes in the uterus are linked to repeated IVF failure or recurrent miscarriage. The goal is to better understand why some women struggle to get pregnant or stay pregnant.
This study tests embryos before pregnancy using genetic screening to look for extra or missing chromosomes, in people who have had repeated IVF embryo transfers without success. It may help reduce the chance of transferring embryos that are unlikely to result in a healthy pregnancy.
This study looks at “biomarkers” (test signals in your blood or cycle data) to better judge how ready the womb lining is during IVF. It compares two types of IVF hormone setups to see which approach best matches endometrial receptivity and supports successful embryo transfer.
This study looks at immune-related blood patterns and other measurements to better understand why some women have repeated pregnancy loss or repeated IVF implantation failure. If you qualify, your answers and test results may help researchers identify biomarkers that could guide future care.
Hear when a new Recurrent Implantation Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.